UTHR — UNITED THERAPEUTICS CORP

Ownership history in SUMMIT SECURITIES GROUP LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which SUMMIT SECURITIES GROUP LLC reported a position in UNITED THERAPEUTICS CORP (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q3)
Avg. % of fund
0.01%
First filed
2013 Q2
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 188 +88 +88.0% 0.02% $79K $419.21
2014 Q4 REDUCED 100 -100 -50.0% 0.00% $13K $129.49
2014 Q1 ADDED 200 +50 +33.3% 0.01% $19K $94.03
2013 Q2 INITIATED 150 — — 0.00% $10K —
% of Fund (quarterly)    UTHR price (monthly, adj. close)

Other funds also holding UTHR

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 15.71% Avoro Capital Advisors LLC 3Y 7Y 12.48% Tri Locum Partners LP 3Y 7.65% Nepsis Inc. 3Y 7Y 6.59% Eversept Partners, LP 3Y 7Y 6.2% Summit Street Capital Management, LLC 3Y 7Y 4.36% Polaris Capital Management, LLC 3Y 7Y 4.19% Nitorum Capital, L.P. 3Y 7Y 3.99% Palo Alto Investors LP 3Y 7Y 3.95% First Turn Management, LLC 3.54%
← Back to SUMMIT SECURITIES GROUP LLC Holdings